Top news of the week: 12.01.2022.
Companies And Industries
Global Roundup: Clover Biopharmaceuticals Builds R&D Center in China
Biopharma and life sciences companies and organizations provide updates on their businesses and pipelines.
STAT@JPM: Will 2022 bring biotech renewal?
The STAT team takes a look at the impact of the JPM conference on the world of biotech
Exxon buys stake in biofuels company Biojet in clean energy push
Oil major Exxon Mobil Corp said on Tuesday it bought a 49.9% stake in Norwegian biofuels company Biojet AS, as it looks to strengthen its low-carbon business to aide its targets for ...
New Biotech Earns $85 Million in Series A Funding
Ambagon Therapeutics closes its first financing round with $85 million. The Series A funds will help advance the company's drug discovery platform and molecular glue pipeline.
Precision Immunology Biotech Rebrands and Scores $200 Million
Formerly Esker Therapeutics, a San Francisco-based biotech company, now named Alumis, closed on a $200 million Series B financing round to help advance its precision immunology medicines.
How a Berlin-Based Biotech Pushes the Limits of Immune Cell Monitoring
Immune cell monitoring is important in many clinical studies. But procedures require viable cells, often an issue due to sample logistics.
A preview of the burning biotech and health tech questions at JPM 2022
A rundown of what to look for at this year's J.P. Morgan Healthcare Conference.